Moving iPSC-Derived Cardiomyocytes Forward to Treat Myocardial Infarction.
Cell Stem Cell
; 23(3): 322-323, 2018 09 06.
Article
in En
| MEDLINE
| ID: mdl-30193131
ABSTRACT
Human pluripotent stem cell-derived cardiomyocytes represent a promising cell source for cardiac repair. However, their clinical translation is hindered by limited evidence for functional benefits in primate models, potential risks for arrhythmias, and teratoma formation. A recent study by Liu et al. (2018) makes significant progress on these critical issues.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Induced Pluripotent Stem Cells
/
Human Embryonic Stem Cells
/
Myocardial Infarction
Limits:
Animals
/
Humans
Language:
En
Journal:
Cell Stem Cell
Year:
2018
Document type:
Article
Affiliation country:
United States